Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
146
-
Total 13F shares, excl. options
-
51.8M
-
Shares change
-
+656K
-
Total reported value, excl. options
-
$479M
-
Value change
-
-$13.2M
-
Put/Call ratio
-
2.26
-
Number of buys
-
89
-
Number of sells
-
-56
-
Price
-
$9.24
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q4 2021
178 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q4 2021.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 146 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.8M shares
of 127M outstanding shares and own 40.85% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (8.46M shares), BlackRock Inc. (8.24M shares), STATE STREET CORP (5.4M shares), VANGUARD GROUP INC (4.3M shares), Granahan Investment Management, LLC (2.25M shares), Soleus Capital Management, L.P. (2M shares), Assenagon Asset Management S.A. (1.27M shares), MILLENNIUM MANAGEMENT LLC (1.19M shares), Nuveen Asset Management, LLC (1.11M shares), and TWO SIGMA ADVISERS, LP (995K shares).
This table shows the top 146 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.